NEW YORK (GenomeWeb) – German molecular diagnostics firm GNA Biosolutions said today that it has closed a E6 million ($6.7 million) Series B financing round.

New investor Robert Bosch Venture Capital led the financing. Other new investors include SHS Gesellschaft für Beteiligungsmanagement GmbH, b-to-v Partners, and UnternehemerTUM-Fonds, and join existing shareholders Mey Capital Matrix, KfW, and company founders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports

By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.

In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.

Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.